RPE cells displaying cobblestone morphology. Cells were immunolabeled with tight-junction ZO-1 marker (shown in green) and co-stained with nuclei marker, Hoechst (shown in blue). Image Credit: ...
Retinal pigment epithelium market is poised for notable growth, being fueled by several factors, including an aging population, advancements in AI-driven diagnosis, industry collaborations, and novel ...
Researchers identify five distinct cell subpopulations in the retinal pigment epithelium using artificial intelligence (AI), which could explain different severities of retinal degenerative diseases.
Researchers have identified distinct differences among the cells comprising a tissue in the retina that is vital to human visual perception. The scientists from the National Eye Institute (NEI) ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, No. 21 (May 25, 2021), pp. 1-12 (12 pages) Loss of the retinal pigment epithelium (RPE) because of ...
Healios, Sumitomo begin phase I/II trial of allogeneic iPS cells in retinal pigment epithelium tears
Japan’s Pharmaceutical and Medical Devices Agency has cleared Healios K.K. and Sumitomo Pharma Co. Ltd. to begin a phase I/II study of HLCR-011, which is composed of retinal pigment epithelial (RPE) ...
Retinal degeneration leads to irreversible vision loss, significantly impacting quality of life. Approximately 19.83 million Americans over 40 have age-related macular degeneration (AMD), a leading ...
Dysregulation of retinal pigment epithelium (RPE) cells is the main cause of a variety of ocular diseases. Potentially heat shock proteins, by preventing molecular and cellular damage and modulating ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results